Nuevas perspectivas en el tratamiento de la Esclerosis múltiple

Autor:	F.T. Salinas Vela, C. Arcos Sánchez, M.N. Olmedilla González
Rok vydání:	2011
Předmět:	Gynecology medicine.medical_specialty tratamiento business.industry terapia farmacológica Multiple sclerosis Esclerosis múltiple General Engineering medicine General Earth and Planetary Sciences medicine.disease business General Environmental Science
Zdroj:	Sanidad Militar v.67 n.2 2011 SciELO España. Revistas Científicas Españolas de Ciencias de la Salud instname
Popis:	New perspectives in the treatment of Multiple Sclerosis SUMMARY A best knowledge of etiopathogeny and prognosis of Multiple Sclerosis is allowing the development of new and more effective therapies. Current therapies are divided into three groups: treatments for the acute relapses, disease-modifying therapy and symptomatic treatment. There are six approved drugs available in Spain, also there are two oral new drugs (Cladribina and Fingolimod) and others designed for improving the quality of life of these patients (Frampidina and Sativex) waiting to be approved and some others in different stages of clinical trials that will offer encouraging perspectives in a near future.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d176cd3c3bd5662ffb494b42750f7245 http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1887-85712011000200009 Zobrazit plný text záznamu